A serious adverse effect associated mainly with conventional antipsychotic medications that consists of abnormal, involuntary movements usually involving the tongue and mouth and sometimes involving the arms and trunk. The treatment is to stop the antipsychotic medication, but many patients choose to continue taking the medication because their life may be intolerable without it. African americans are at greater risk for developing tardive dyskinesia. The risk of this disorder is much lower with atypical antipsychotic medications.
A long-term side effect of major tranquilizers, characterized by the inability to control the lips and tongue.
Tardive dyskinesia (TD), which means late abnormal movement, is an iatrogenic effect of long-term use of neuroleptic or antipsychotic medications. Individuals who have been on chronic antipsychotic medications may develop uncontrollable movements, ranging from mild tongue movements to chorea, that impair their daily life. They may have problems with manual dexterity, eating, speaking, and even breathing. Symptoms may (a) increase under stress, during voluntary motor activity, and during attempts to inhibit the movements; (b) decrease under sedation; and (c) disappear during sleep. After medication is discontinued, TD may gradually diminish in severity or persist and become permanent. Therefore, prevention is crucial.
A movement disorder characterized by involuntary, fragmented movements of the mouth, face, and jaw (i.e., chewing, sucking, tongue protrusion, and the like). This disorder may occur during the prolonged administration of antipsychotic drugs.
Abnormal condition characterized by involuntary and repetitious movements of muscles of the face, trunk, and limbs; most often occurring as a side effect in people treated with phenothiazine drugs for Parkinsonism, or in patients taking antipsychotic medications.
A complication of treatment with antipsychotic medications that produces abnormal, involuntary, repetitive movements of the face (grimacing, lip smacking, eye blinking, tongue movements) and can also include movements of the arms and legs.
Also known as orofacial dyskinesia, this is characterized by involuntary chewing and grimacing, usually the result of taking antipsychotic drugs, particularly over a long period. It is rare in those using these drugs for less than 6 months or on a low dose. The overall risk is said to be 5 per cent per year of those treated. While it may disappear when the medication is stopped, it is often permanent. Advice is available from the Dystonia Society.
A neurological syndrome marked by slow, rhythmical, stereotyped movements, either generalized or in single muscle groups. These occur as an undesired effect of therapy with certain psychotropic drugs, especially the phenothiazines.
Tardive dyskinesia is a condition characterized by uncontrollable and involuntary movements of the face and/or body, which arise as an unintended consequence of prolonged utilization of certain older antipsychotic (neuroleptic) medications. Approximately 15-20% of individuals undergoing long-term neuroleptic treatment experience the effects of tardive dyskinesia. These involuntary movements can significantly impact the quality of life and overall well-being of affected patients.
Irregular and involuntary motions, primarily affecting the face, tongue, mouth, and neck, characterize tardive dyskinesia. Prolonged usage of antipsychotic medications can trigger this condition, which is separate from the movement disorder known as parkinsonism.